To test whether activation of MYC target genes and repression of immune genes is a general function of RUVBL1 in pancreatic cancer cells, we treated five further murine PDAC lines with different genetic backgrounds with CB-6644 for 24 hours and analysed gene expression by RNA sequencing. The gene discussed is RUVBL1; the disease is familial pancreatic carcinoma.